Robert E. Landry
Board Member
Cytokinetics Inc (CYTK)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Robert E. Landry
Robert E. Landry is recorded as Board Member at Cytokinetics Inc (CYTK). Cytokinetics Inc reported in an 8-K filed February 11, 2025 that Robert E. Landry was appointed Class II member of the Board, effective February 10, 2025.
“On February 10, 2025, (the "Effective Date"), the Board of Directors (the "Board") of Cytokinetics, Incorporated (the "Company") appointed, upon the recommendation of the Nominating and Governance Committee of the Board, Robert E. Landry to fill a vacant Board seat and to serve as a Class II member of the Board with an initial term expiring at the Company's 2027 annual meeting of stockholders.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-02-10–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Cytokinetics Inc
Other people whose current roles at this company are on record from its filings.
- Robert Blum CEO
- Robert I. Blum CEO, Board Member
- John T. Henderson, M.D. Chairman
- Sung H. Lee CFO
- Brett Pletcher General Counsel
- Jeffrey J. Hessekiel General Counsel
- Mark A. Schlossberg General Counsel
- Mr. Schlossberg General Counsel
- Mr. Wong Chief Accounting Officer
- Robert Wong Chief Accounting Officer
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.